首页> 外国专利> HUMANIZED MONOCLONAL ANTIBODY IN EXTRACELLULAR DOMAIN OF ANTI-HUMAN DEATH RECEPTOR 5

HUMANIZED MONOCLONAL ANTIBODY IN EXTRACELLULAR DOMAIN OF ANTI-HUMAN DEATH RECEPTOR 5

机译:抗人类死亡受体5细胞外域的人源化单克隆抗体

摘要

The present invention provides a humanized monoclonal antibody in an extracellular domain of an anti-human death receptor 5 (DR5), comprising a light chain variable region amino acid sequence which has at least 90% identity of an amino acid sequence shown by the SEQ ID NO:1, a heavy chain variable region amino acid sequence which has at least 90% identity of an amino acid sequence shown by the SEQ ID NO:2, and a constant region with a human antibody function IgG1. The present invention further provides a coding nucleotide sequence of the humanized monoclonal antibody, a recombination eukaryon expression vector, and a production method for the antibody, composition and use thereof. The humanized monoclonal antibody of the present invention has a specific apoptosis inducing activity on various tumor cells in vitro and vivo, may be used alone or used in combination with a natural ligand tumor necrosis factor related apoptosis inducing ligand of the DR5 or other drugs, and used for treatment of various tumors and diseases related to high expression of the DR5.
机译:本发明提供了抗人死亡受体5(DR5)的细胞外结构域中的人源化单克隆抗体,其包含与SEQ ID NO:1所示的氨基酸序列具有至少90%同一性的轻链可变区氨基酸序列。 NO:1,具有与SEQ ID NO:2所示氨基酸序列至少90%同一性的重链可变区氨基酸序列,以及具有人抗体功能IgG1的恒定区。本发明进一步提供了人源化单克隆抗体的编码核苷酸序列,重组真核表达载体,以及该抗体的生产方法,组成和用途。本发明的人源化单克隆抗体在体外和体内对各种肿瘤细胞具有特异性的凋亡诱导活性,可以单独使用或与天然配体肿瘤坏死因子相关的DR5或其他药物的凋亡诱导配体结合使用,和用于治疗与DR5高表达有关的各种肿瘤和疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号